Affordability is access, and helping patients save up to $1,200 per year on Wegovy is a meaningful step toward breaking down that barrier for millions more people," said Zach Reitano, CEO and co-founder of Ro
In 2003, there seemed to be good reasons to leave weight-loss drugs out of the benefit, write Inmaculada Hernandez of the University of California, San Diego, and coauthors in their September 2023 editorial in the Journal of General Internal Medicine, Medicare Part D Coverage of Anti-obesity Medications: a Call for Forward-Looking Policy Reform. When members of Congress worked on the Part D benefit, the drugs available on the market were known to have limited effectiveness and unpleasant side effects
At 6 mg/mL, 1.2 mg equals 0.2 mL, or 20 units
Nat Commun
This is a therapeutic dose, but not an aggressive one